These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Vigabatrin and lamotrigin: experiences with 2 new anticonvulsants in the Swiss epilepsy clinic]. Vogt H, Krämer G. Schweiz Med Wochenschr; 1995 Jan 28; 125(4):125-32. PubMed ID: 7878401 [Abstract] [Full Text] [Related]
5. Vigabatrin in drug-resistant epilepsy. Buchanan N. Med J Aust; 1993 Sep 06; 159(5):356. PubMed ID: 8361442 [No Abstract] [Full Text] [Related]
6. Vigabatrin: a three year clinical analysis. Martin PJ, Millac PA. Seizure; 1993 Jun 06; 2(2):137-40. PubMed ID: 8167965 [Abstract] [Full Text] [Related]
7. Six-year follow-up study on the efficacy and safety of vigabatrin in patients with epilepsy. Tartara A, Manni R, Galimberti CA, Morini R, Mumford JP, Iudice A, Perucca E. Acta Neurol Scand; 1992 Sep 06; 86(3):247-51. PubMed ID: 1414241 [Abstract] [Full Text] [Related]
15. EEG changes induced by vigabatrin monotherapy in focal epilepsy. Marciani MG, Stanzione P, Maschio M, Spanedda F, Bassetti MA, Mattia D, Bernardi G. Acta Neurol Scand; 1997 Feb 11; 95(2):115-20. PubMed ID: 9059732 [Abstract] [Full Text] [Related]
16. Single-blind, placebo-controlled multicenter trial of vigabatrin in the treatment of epilepsy. The Italian Study Group on Vigabatrin. Ital J Neurol Sci; 1992 Dec 11; 13(9):741-7. PubMed ID: 1483856 [Abstract] [Full Text] [Related]